We studied the distribution of the two enzymes involved in post-translational C-terminal a-amidation of regulatory peptides in rat digestive tract, using immunocytochemical methods and in situ hybridization techniques. The enzymes were located in most of the fibers and neurons of the myenteric and submucous plexus throughout the entire digestive tract and in endocrine cells of the stomach and colon. Staining of reverse-face serial sections demonstrated that the enzymes in endocrine cells of the stomach co-localized with gastrin in the bottom of the gastric glands. Some gastrinimmunoreactive cells near the neck of the gland were negative for PAM, suggesting that amidation takes place only in 1993)
Introduction
The neuroendocrine system of the gastrointestinal tract consists of the neurons of the enteric plexus and a set of dispersed endocrine cells widely distributed in the epithelia of the various organs. This system is responsible for the secretion of many different regulatory peptides (Rawdon and Andrew, 1990; Polak, 1989) .
Before maturation is completed, peptides undergo multiple posttranslational processing steps. For some of the bioactive peptides one of these steps consists of a-amidation of the C-terminal amino acid of the precursor peptide. This a-amidation is a two-step process catalyzed by two separate enzyme activities, both derived from the peptidyl-glycine a-amidating monooxygenase (PAM) precursor, a 108 KD polypeptide (Milgram et al., 1992; Stoffers et al., 1991; Glauder et al., 1990) .
The NHz-terminal third of the PAM precursor contains the first enzyme, peptidylglycine a-hydroxylating monooxygenase (PHM), that catalyzes the conversion of glycine-extended peptides into peptidyl-a-hydroxyglycine intermediates. The second enzyme, Correspondence to: Dr. A. Martinez, Dept. of Cytology and Histology, U. of NaParra, 31080 Pamplona, Spain. the more mature cells. In the colon all cells immunoreactive for glucagon and GLPl were also positive for peptidylglycine a-hydroxylating monooxygenase (PHM) but not for peptidyl-a-hydroxyglycine a-amidating I p s e (PAL). The absence of immunoreactivity for the amidating enzymes in endocrine cells of the small intestine, known to produce C-terminally amidated peptides, suggests the existence of other amidating enzymes. (JHistocbem Cytocbem 41:1617-1622, peptidyl-a-hydroxyglycine a-amidating lyase (PAL), is contained in the middle third of the PAM precursor. The COOH-terminal third encodes a transmembrane domain and a hydrophilic domain that may form a cytoplasmic tail ( Figure 1) (Milgram et al., 1993; Milgram et al., 1992; Ouafik et al., 1992; Eipper et al., 1991) .
The presence of PAM enzymes in endocrine organs has been widely reported (e.g.. Martinez et al., 1993; Braas et al., 1992; Bimbaum et al., 1989; Markosian et al., 1989) . Except for the pancreatic islets (Martinez et al., 1993) , expression of PAM in the diffuse endocrine system has not been studied.
The present study used rat digestive tract as a model to investigate, by immunocytochemical and in situ hybridization methods, which cells of the neuroendocrine system express PAM enzymes, and whether amidated regulatory peptides co-localize with amidating enzymes in this system.
Materials and Methods
Antisera. Two polyclonal antisera were raised against synthetic peptides of the PAM molecule as previously reported (Martinez et al., 1993) . The antiserum named CC was raised to a peptide from the PHM domain of the human PAM (288-310) and antiserum PAL2 was raised to the peptide 527-546. inside the PAL region ( Figure 1 ).
To localize endocrine cells, various polyclonal antisera raised to several Immunocytochemistry. Tissues from adult Wistar rats (stomach, small intestine, and colon) were fixed in Bouin's fluid for 6-8 hr, dehydrated, and embedded in paraffin. Serial reverse-face sections (Osamura et al., 1980) were used to show the coexistence of immunoreactivities in the same cells. After dewaxing, immunocytochemical staining was performed by the avidin-biotin method (Hsu et al., 1981) . Sections were pre-treated with 3% HzOz in methanol for 30 min and with normal swine serum (NP-1, 1:20; University of Navarra) for 30 min. After overnight incubation at 4'C with the primary antisera, sections were incubated for 30 min with biotinylated anti-rabbit immunoglobulins (E353) (Dakopatts; Glosuup, Denmark), followed by a third incubation with avidin-biotinylated-peroxidase complexes (K355) (Dakopatts) for 30 min. After each incubation, sections were rinsed with Pis-HC1-buffered saline (TBS 0.05 M, pH 7.36, 0.55 M NaCI). The sections were then washed in Trk-HC1 buffer (0.05 M, pH 7.36) and the peroxidase activity revealed by incubation in a solution of 0.03% 3,3'-diaminobenzidine tetrahydrochloride (D-5637) (Sigma) and 0.006% H202 in Tris-HC1. The sections were counterstained with hematoxylin.
To test the specificity of the reagents, the following controls were done on each specimen: (a) omission of the primary antibodies; (b) application of primary antibodies previously absorbed by incubation overnight at 4°C with 1-10 m o l of the synthetic peptide antigens per ml of optimally diluted antiserum; and (c) staining with DAB/HzOz alone.
In Situ Hybridization. Pieces of tissue were fixed in 4% paraformaldehyde in 0.15 M sodium phosphate buffer, pH 7.5, for 4 hr, washed in 70% ethanol, and embedded in paraffin. Four-pm thick sections were mounted on Vectabond (SP-1800) (Vector; Burlingame, CA)-coated slides, dewaxed, and prepared for hybridization to RNA probes as described by Gibson and Polak (1990) . A plasmid named hPAM1200, containing 1200 BP ofthe human PAM gene (Glauder et al., 1990) (Figure I) , was kindly donated by Prof. Engels (Frankfurt, Germany) and used to generate riboprobes. In summary, the DNA fragment was subcloned into Bluescript I1 SK( +) (Stratagene;
La Jolla, CA) and linearized with the appropriate restriction enzymes. Labeled probes were prepared with ~g e n i n -l l -U P (1277 073) (Boehriner; t t Barcelona, Spain) and T7 (881 767 Visualization of digoxigenin was performed with a monoclonal antibody coupled to alkaline phosphatase (1093 274) (Boehringer) 1500 for 2 hr at room temperature. Niuoblue tetrazolium chloride (N-5514) (Sigma) and 5-bromo-4-chloro-3-indolyl-phosphate (B-8503) (Sigma) were used as substrates for the alkaline phosphatase, obtaining a deep-blue precipitate.
Controls included the use of the sense probe and digestion with RNAse before the hybridization.
Results
Table 1 summarizes the immunocytochemical results obtained in the present study.
Neurons
Nerve fibers and neuronal bodies of the myenteric and submucous plexuses were stained with the PAM antibodies throughout the entire digestive tract (Figure 2A ). The immunoreactivity for PAM colocalized with the immunostaining for PGP 9.5, a known neuronspecific marker. The in situ hybridization technique labeled the neuronal bodies but not the fibers ( Figure 2B ).
Endocrine C e h
A large number of cells immunoreactive for the PAL antibody were found in the antrum, particularly at the bottom of the gastric glands (Figure 3A) . Only a subset of these cells showed staining with the PHM antiserum.
With antisera against different regulatory substances known to be present in the gastric endocrine cells, many CCKI-immuno- Figure 3B ) and a moderate number of somatostatinand serotonin-like cells were observed. CCK8 antiserum was completely inactivated when pre-absorbed with the tetrapeptide WMDF amide (T6515) (Sigma), indicating that this antiserum detects the C-terminal sequence of the gastrinlCCK family.
Comparison of the serial reverse-face sections (Figure 3) showed that the number of gastrinlCCK cells was higher than the number of those reacting with the PAM antisera and that all the PAMimmunoreactive cells were also positive for CCK8. Cells positive for CCK8 and not for PAM were mainly located in the regions of the gastric glands more proximal to the lumen of the stomach ( Figure  3) . No PAM immunoreactivity was present in the somatostatin-or serotonin-positive cells.
In situ hybridization studies showed similar results to those obtained with immunocytochemistry: many cells in the bottom of the glands expressed PAM mRNA ( Figure 3C) .
No immunoreactivity to any of the PAM antibodies was found in endocrine cells of the epithelium of the small intestine, although many cells containing amidated regulatory peptides (CCK, secretin, substance P) were present (Figure 4) .
In situ hybridization observations in the small intestine were consistent with the immunocytochemical results: PAM mRNA was detected only in neurons.
After applying the different PAM antisera in colon, a moderate number of cells were detected only when the PHM antibody was used (Figure ) A). When GLPl or glucagon immunoreactivity was compared with serial sections stained with PAM antibodies, colocalization of these three molecules was demonstrated ( Figures 5A  and 5B ). Neural structures in this organ were stained with both PHM and PAL antibodies. All the neurons and some of the endocrine cells showed PAM mRNA after hybridization with the antisense probe ( Figure 5C ).
Discussion
This study shows that the two amidating enzymes PHM and PAL, known to be derived from the PAM precursor, are present in the rat digestive tract. They appear both in the neural structures and in endocrine cells.
Most, if not all. of the enteric neurons express the amidating enzymes. The gut intrinsic neurons are known to store and release amidated peptides such as VIP, PHI, galanin, NPY, and PYY (Chevendra and Weaver, 1992; Rokaeus and Brownstein, 1986; Itoh et al., 1983; Etemoto, 1982; Etemoto and Mutt, 1981) . This is the first time that PAM enzymes have been localized in the peripheral nervous system with immunocytochemistry and in situ hybridization. PAM immunoreactivity appears in all the neural cell bodies and fibers throughout the digestive tract wall. The presence of these enzymes in the central nervous system is well known (Schafer et al., 1992; Rhodes et al., 1990 ). a-amidating activity was previously reported in extracts of rat small intestine (Noguchi et al., 1988) . These authors related the amidating activity found to the processing of VIP.
The in situ hybridization images of the plexuses showed labeling only in the perinuclear cytoplasm of the neurons, as could be expected for the mRNA distribution in neurons, whereas immunocytochemistry labeled fibers as well as neuronal bodies, probably because the secretory granules along with the enzymes undergo anterograde transport (Tozawa et al., 1990) . Localization of the PAM enzymes in the mature secretory granules has already been shown in human pancreatic endocrine cells (Martinez et al., 1993) .
The present study is also the first report of the expression of PAM enzymes in endocrine cells of the diffuse endocrine system other than pancreatic islet cells. In gut endocrine cells are many cell types that produce amidated peptides, among others the gastrin cells of the stomach (Dickinson et al., 1992; Dickinson and Yamada, 1991; Marino et al., 1991) and the cells that synthesize GLPl in the intestine (Mojsov, 1992; Orskov et al., 1989) .
The importance of amidation in the case of gastrin has already been suggested, as it is necessary for the peptide to achieve its complete biological activity (Dickinson et al., 1990) . From this point of view the co-localization of PAM and gasuin is ofgreat significance:
our study shows that cells containing both immunoreactivities were mainly located in the deeper part of the glands. Considering that the endocrine cells originate in the neck of the gland and migrate to the deeper regions (Thompson et al., 1990) , our results suggest that the amidating enzyme machinery is present only in more mature cells. Therefore, the cells of the upper part of the glands, immunoreactive for gastrin and not for PAM, probably could contain an inactive form of gastrin. In a similar way, amidation of gastrin has been proven a key regulatory step in gastrin secretion onset in the late phases of the fetal development in sheep (Read et al., 1992) .
The differences in the number of cells stained with the PHM and the PAL antisera in stomach are difficult to explain, but suggest the involvement of complex post-translational regulatory phenomena for the amidating enzymes in these cells.
In colon, only immunoreactivity for PHM was found, whereas the PAL antibody gave negative results. PHM by itself can complete the amidating process at alkaline pH because the second step is spontaneous under such conditions (Noguchi et al., 1989) . Further studies are needed to investigate if this is the case in the gluca-gonlGLP1-containing cells of the colon.
The absence of PAM immunoreactivity in other cells known to possess amidated peptides in the small intestine is difficult to ex-plain. It is well known that cholecystokinin, secretin, and substance P are amidated peptides (Eberlein et al., 1992; Nawa et al., 1984; Nilsson et al., 1980) and that they are present in many endocrine cells of the small intestine, but neither PAM immunoreactivity nor PAM mRNA was found in the epithelium of this region whereas, in the same sections, neural PAM expression was detected. Two possible interpretations can be given to explain this lack of PAM positivity. First, there is the possibility of tissue-specific isoforms of PAM that could not be detected by our antibodies and riboprobe. Second, a different amidating enzyme could exist apart from PAM. We have recently suggested the same possibilities for the PP-producing cells in human pancreas (Mm'nez et al., 1993) . The presence of positive neurons in the same sections and the staining of endocrine cells in other regions of the gut make less likely the explanation that the lack of staining is related to fixation.
In summary, PAM immunoreactivity has been located in enteric neurons and epithelial endocrine cells where the presence of amidated peptides is well known. The colon cells positive for glucagon and GLPl were immunoreactive only for PHM, pointing to a different amidating pathway in these cells. Furthermore, the lack of PHM/PAL. immunoreactivities in the endocrine cells of the small intestine suggests that other peptide-amidating enzyme systems may exist, and this merits further investigation. 
